Fidaxomicin: Data subsequently submitted by manufacturer prove added benefit

Now proof of minor added benefit in severe cases or recurrences of Clostridium difficile infections

2013-07-24

(Press-News.org) In the commenting procedure on early benefit assessment pursuant to the German Act on the Reform of the Market for Medicinal Products (AMNOG), under certain circumstances drug manufacturers may submit to the Federal Joint Committee (G-BA) additional documents for dossiers. The Institute for Quality and Efficiency in Health Care (IQWiG) has now assessed such additional information for two studies comparing the antibiotic fidaxomicin, which is used for diarrhoea caused by Clostridium difficile infections, with vancomycin.

In contrast to the first dossier assessment, the Institute now sees proof of a minor added benefit of fidaxomicin versus the appropriate comparator therapy in patients with severe or recurrent disease. An added benefit is still not proven in patients with mild disease; the manufacturer provided no new data for this indication.

Manufacturer dossier did not allow an overall conclusion

The antibiotic fidaxomicin (trade name: Dificlir) has been approved in Germany since December 2011 for the treatment of adults with diarrhoea caused by Clostridium difficile. IQWiG already presented an assessment pursuant to AMNOG in April 2013.

On the basis of the dossier submitted by the manufacturer, an advantage of fidaxomicin for the outcome "global cure" could be inferred for severe cases and recurrences. However, the magnitude of this advantage could not be inferred from the data presented. In addition, it could not be excluded that more severe side effects occurred precisely in these cases, thus outweighing advantages with regard to global cure. An overall conclusion on added benefit was therefore not possible.

Greater harm not proven in patients with severe disease

In the commenting procedure the manufacturer subsequently provided study results in a form that allows the weighing of positive and negative effects. Whereas no statistically significant difference between fidaxomicin and vancomycin was shown for all-cause mortality, the data provide proof of an added benefit for the outcome "global cure" in patients with severe or recurrent disease. In addition, in these subpopulations there is no suggestion of greater harm from fidaxomicin than from vancomycin.

An overall conclusion is thus possible: an added benefit of fidaxomicin versus the appropriate comparator therapy (vancomycin) is now proven for the treatment of patients with severe or recurrent Clostridium difficile infections. IQWiG classifies the extent of added benefit as minor.

An added benefit in patients with mild disease was not claimed by the manufacturer.

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturer's dossier and the IQWiG dossier assessment, the G-BA conducted a commenting procedure in which the manufacturer submitted additional information. The G-BA subsequently commissioned IQWiG on 28 May 2013 to undertake a new assessment including the additional data.

If, in the course of the discussions on a commission of the G-BA, a need for further revision arises, IQWiG presents its report in the form of an addendum. The Institute sent this addendum to the contracting agency (the G-BA) on 12 June 2013. The G-BA then decides on the extent of the added benefit in each case, thus completing the early benefit assessment.

### The website gesundheitsinformation.de, published by IQWiG, provides easily understandable and brief German-language information on fidaxomicin (English-language information [addendum and health information] will also be available in the near future; if you would like to be informed when this is published, please send an email to info@iqwig.de).

The G-BA website contains both general English-language information on benefit assessments pursuant to §35a Social Code Book V and specific German-language information on the assessment of fidaxomicin.

ELSE PRESS RELEASES FROM THIS DATE:

A magnetic pen for smartphones adds another level of conveniences

2013-07-24

Daejeon, Republic of Korea, July 24, 2013 – A doctoral candidate at the Korea Advanced Institute of Science and Technology (KAIST) developed a magnetically driven pen interface that works both on and around mobile devices. This interface, called the MagPen, can be used for any type of smartphones and tablet computers so long as they have magnetometers embedded in. Advised by Professor Kwang-yun Wohn of the Graduate School of Culture Technology (GSCT) at KAIST, Sungjae Hwang, a Ph.D. student, created the MagPen in collaboration with Myung-Wook Ahn, a master's student ...

Solar system's youth gives clues to planet search

2013-07-24

Washington, D.C.—Comets and meteorites contain clues to our solar system's earliest days. But some of the findings are puzzle pieces that don't seem to fit well together. A new set of theoretical models from Carnegie's Alan Boss shows how an outburst event in the Sun's formative years could explain some of this disparate evidence. His work could have implications for the hunt for habitable planets outside of our solar system. It is published by The Astrophysical Journal. One way to study the solar system's formative period is to look for samples of small crystalline particles ...

An evolutionary compromise for long tooth preservation

2013-07-24

This news release is available in German. Researchers at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, and the Senckenberg Research Institute in Frankfurt am Main, Germany, have conducted stress analyses on gorilla teeth of differing wear stages. Their findings show that different features of the occlusal surface antagonize tensile stresses in the tooth to tooth contact during the chewing process. They further show that tooth wear with its loss of dental tissue and the reduction of the occlusal relief decreases tensile stresses in the ...

New study reveals dangers to biological diversity from global cashmere garment industry

2013-07-24

A new study by the Wildlife Conservation Society and Snow Leopard Trust reveals a disturbing link between the cashmere trade and the decay of ecosystems that support some of the planet's most spectacular yet little-known large mammals. The study finds that as pastoralists expand goat herds to increase profits for the cashmere trade in Western markets, wildlife icons from the Tibetan Plateau to Mongolia suffer – including endangered snow leopard, wild yak, chiru, saiga, Bactrian camel, gazelles, and other remarkable but already endangered species of remote Central Asia. ...

Pressurized virus blasts its infectious DNA into human cells

2013-07-24

The virus that causes those painful lip blisters known as cold sores has an internal pressure eight times higher than a car tire, and uses it to literally blast its infectious DNA into human cells, scientists are reporting in a new study. Discovery of the pressure-driven infection mechanism — the first in a human virus — opens the door to new treatments for viral infections, they add in a study in the Journal of the American Chemical Society. Alex Evilevitch and colleagues point out that the viruses responsible for influenza, AIDS and other infections that affect millions ...

Dark chocolate lovers show higher tolerance for bitterness in chocolate ice cream

2013-07-24

Philadelphia, PA, July 24, 2013 – To make the inherent bitterness of cocoa in chocolate ice cream more palatable, manufacturers add high levels of fat and sugar. Yet, bitterness is an integral part of the complex flavor of chocolate. In a new study published in the August issue of the Journal of Dairy Science®, investigators report that consumers who prefer dark chocolate in solid form tolerate twice the amount of bitter ingredients in chocolate ice cream than those who prefer milk chocolate. Elimination of some added sugar and fats in chocolate ice cream may be acceptable, ...

Study explains why Africans may be more susceptible to tuberculosis

2013-07-24

PHILADELPHIA—A researcher from the Perelman School of Medicine at the University of Pennsylvania and colleagues have identified the genetic mutation in Africans with HIV that puts them at a much higher risk for tuberculosis (TB) infections. Africans have some of the highest rates of TB in the world, and it has long been suspected that genetic susceptibility plays a role. However, establishing candidate genes across populations to gauge risk has remained a challenge. Now, a new study, published this week in the online Early Edition of the Proceedings of the National ...

Brothers and sisters learn to build positive relationships in SIBS Program

2013-07-24

Little is known about how sibling relationships impact child and family functioning, but Penn State researchers are beginning to shed light on intervention strategies that can cultivate healthy and supportive sibling relationships. Parents frequently rank their children's sibling rivalry and conflict as the number one problem they face in family life. "In some other cultures, the roles of older and younger, male and female siblings are better defined, and in those more-structured family relationships, there is not much room for bullying and disrespect," said Mark Feinberg, ...

Record incidence of hantavirus disease

2013-07-24

2824 new cases of hantavirus disease were reported in Germany in 2012, the highest number ever in a single year. In the current issue of Deutsches Ärzteblatt International, Detlev Krüger and coauthors present the main facts about this disease (Dtsch Arztebl Int 2013; 110[27-28]: 461-7). Every two to three years, large outbreaks of hantavirus disease are caused by Puumala virus, which is transmitted by bank voles and is endemic to southwestern and western Germany. In the north and east of the country, hantavirus infections are caused by the Dobrava-Belgrad virus, which ...

First human tests of new biosensor that warns when athletes are about to 'hit the wall'

2013-07-24

A new biosensor, applied to the human skin like a temporary tattoo, can alert marathoners, competitive bikers and other "extreme" athletes that they're about to "bonk," or "hit the wall," scientists are reporting. The study, in ACS' journal Analytical Chemistry, describes the first human tests of the sensor, which also could help soldiers and others who engage in intense exercise — and their trainers — monitor stamina and fitness. Joseph Wang and colleagues explain that the sensor monitors lactate, a form of lactic acid released in sweat. Lactate forms when the muscles ...

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Fidaxomicin: Data subsequently submitted by manufacturer prove added benefit

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: